Showing results (151-160 of 251) with videos related to

Sort By:
Pageof 26
Journal of Clinical Apheresis|June 4, 1999
Kinetic study of CD34+ cells during peripheral blood stem cell collectionsP Bojko, W Stellberg, C Küdde, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
Thymidylate synthase inhibitors in cancer therapy: direct and indirect inhibitorsY M Rustum, A Harstrick, S Cao, et al.
American Journal of Clinical Oncology|June 17, 2000
Induction chemotherapy followed by concurrent chemotherapy and high-dose radiotherapy for locally advanced squamous cell carcinoma of the upper-thoracic and midthoracic esophagusM Stuschke, M Stahl, H Wilke, et al.
Cytotherapy|June 5, 2002
Optimized retroviral transduction protocol for human progenitor cells utilizing fibronectin fragmentsT Trarbach, S Greifenberg, W Bardenheuer, et al.
Leukemia Research|May 21, 1998
Chronic myelogenous leukemia: effect of interferon-alpha treatment on phagocytic activity and capacity of circulating neutrophilsS Kasimir-Bauer, H Ottinger, M Wuttke, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 10, 1998
Simulation of 3D-treatment plans in head and neck tumors aided by matching of digitally reconstructed radiographs (DRR) and on-line distortion corrected simulator imagesF Lohr, O Schramm, P Schraube, et al.
Klinische Wochenschrift|December 4, 1989
[Sequential induction chemotherapy and radiation treatment of inoperable small cell bronchial cancer. Results of a prospective randomized study]J Schütte, N Niederle, W Eberhardt, et al.
Leukemia|May 1, 1994
Bcr-abl-positive and -negative clonogenic cells in CML patients undergoing long-term interferon treatmentU B Wandl, R Bützler, N Niederle, et al.
Anti-Cancer Drugs|March 1, 1997
Phase II trial of continuous oral trofosfamide in patients with advanced colorectal cancer refractory to 5-fluorouracilD Strumberg, A Harstrick, U Klaassen, et al.
Anti-Cancer Drugs|July 11, 1998
Phase II study of continuous 120 h infusion of mitomycin C as salvage chemotherapy in patients with progressive or rapidly recurrent colorectal cancerJ T Hartmann, A Harstrick, T Daikeler, et al.
Pageof 26